| The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial AA Voors, CE Angermann, JR Teerlink, SP Collins, M Kosiborod, J Biegus, ... Nature medicine 28 (3), 568-574, 2022 | 734 | 2022 |
| Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology T Jaarsma, JM Beattie, M Ryder, FH Rutten, T McDonagh, P Mohacsi, ... European journal of heart failure 11 (5), 433-443, 2009 | 681 | 2009 |
| Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial F Koehler, K Koehler, O Deckwart, S Prescher, K Wegscheider, BA Kirwan, ... The Lancet 392 (10152), 1047-1057, 2018 | 674 | 2018 |
| Atrial septal aneurysm in adult patients: a multicenter study using transthoracic and transesophageal echocardiography A Mügge, WG Daniel, C Angermann, C Spes, BK Khandheria, I Kronzon, ... Circulation 91 (11), 2785-2792, 1995 | 591 | 1995 |
| Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy R Jahns, V Boivin, L Hein, S Triebel, CE Angermann, G Ertl, MJ Lohse The Journal of clinical investigation 113 (10), 1419-1429, 2004 | 522 | 2004 |
| Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure G Güder, J Bauersachs, S Frantz, D Weismann, B Allolio, G Ertl, ... Circulation 115 (13), 1754-1761, 2007 | 380 | 2007 |
| Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study D Hilfiker-Kleiner, A Haghikia, D Berliner, J Vogel-Claussen, J Schwab, ... European heart journal 38 (35), 2671-2679, 2017 | 372 | 2017 |
| Mode of action and effects of standardized collaborative disease management on mortality and morbidity in patients with systolic heart failure: the Interdisciplinary Network … CE Angermann, S Störk, G Gelbrich, H Faller, R Jahns, S Frantz, ... Circulation: Heart Failure 5 (1), 25-35, 2012 | 305 | 2012 |
| Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial CE Angermann, G Gelbrich, S Störk, H Gunold, F Edelmann, R Wachter, ... Jama 315 (24), 2683-2693, 2016 | 299 | 2016 |
| Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study S Störk, AW van den Beld, C von Schacky, CE Angermann, ... Circulation 110 (3), 344-348, 2004 | 293 | 2004 |
| GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study G Güder, S Brenner, CE Angermann, G Ertl, M Held, AP Sachs, ... Respiratory research 13, 1-9, 2012 | 238 | 2012 |
| Sustained activation of nuclear factor kappa B and activator protein 1 in chronic heart failure S Frantz, D Fraccarollo, H Wagner, TM Behr, P Jung, CE Angermann, ... Cardiovascular research 57 (3), 749-756, 2003 | 232 | 2003 |
| Pulmonary artery pressure‐guided therapy in ambulatory patients with symptomatic heart failure: the CardioMEMS E uropean M onitoring S tudy for H eart F ailure (MEMS‐HF) CE Angermann, B Assmus, SD Anker, FW Asselbergs, J Brachmann, ... European journal of heart failure 22 (10), 1891-1901, 2020 | 212 | 2020 |
| Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary … CH Spes, V Klauss, H Mudra, SD Schnaack, AR Tammen, J Rieber, ... Circulation 100 (5), 509-515, 1999 | 211 | 1999 |
| A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy B Meder, F Rühle, T Weis, G Homuth, A Keller, J Franke, B Peil, ... European heart journal 35 (16), 1069-1077, 2014 | 180 | 2014 |
| Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study J Tromp, S Bamadhaj, JGF Cleland, CE Angermann, U Dahlstrom, ... The Lancet Global Health 8 (3), e411-e422, 2020 | 179 | 2020 |
| Progression of left ventricular functional abnormalities in hypertensive patients with heart failure: an ultrasonic two-dimensional speckle tracking study W Kosmala, R Plaksej, JM Strotmann, C Weigel, S Herrmann, M Niemann, ... Journal of the American Society of Echocardiography 21 (12), 1309-1317, 2008 | 176 | 2008 |
| Stimulating autoantibodies directed against the cardiac β1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy S Störk, V Boivin, R Horf, L Hein, MJ Lohse, CE Angermann, R Jahns American heart journal 152 (4), 697-704, 2006 | 176 | 2006 |
| Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction F Edelmann, R Stahrenberg, G Gelbrich, K Durstewitz, CE Angermann, ... Clinical Research in cardiology 100, 755-764, 2011 | 173 | 2011 |
| Position paper on the importance of psychosocial factors in cardiology: update 2013 KH Ladwig, F Lederbogen, C Albus, C Angermann, M Borggrefe, ... GMS German Medical Science 12, Doc09, 2014 | 171 | 2014 |